Feasibility, safety and accuracy of dobutamine/atropine stress echocardiography for the detection of coronary artery disease in renal transplant candidates;Exeqüibilidade, segurança e acurácia do ecocardiograma sob estresse com dobutamina/atropina para detecção de doença arterial coronariana em candidatos a transplante renal

Arquivos Brasileiros de Cardiologia

Volumn 88, Issue 1, 2007, Pages 41-47

  Ferreira, Pedro Antonio Muniz ^a,b   De Lima, Valter Correia ^a   Campos Filho, Orlando ^a   Gil, Manuel Adan ^a   Cordovil, Adriana ^a   Machado, Cristiano Vieira ^a   Pestana, José Osmar Medina ^a   Carvalho, Antonio Carlos De Camargo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Ed Maison Lafiti   (Brazil)

Author keywords

Chronic renal failure; Coronary artery disease; Stress echocardiography

Indexed keywords

ATROPINE; DOBUTAMINE; METOPROLOL; CARDIOTONIC AGENT; DIAGNOSTIC AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETIC NEPHROPATHY; DIAGNOSTIC ACCURACY; FEASIBILITY STUDY; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; CHRONIC KIDNEY FAILURE; ECHOGRAPHY; MIDDLE AGED; PREDICTION AND FORECASTING; REPRODUCIBILITY;

ADULT; AGED; ATROPINE; CARDIOTONIC AGENTS; CORONARY DISEASE; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEASIBILITY STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33947315119     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2007000100008     Document Type: Article

References (34)

1. Kasiske B, Guijarro C, Massv ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol. 1996; 7: 158-65.
2. Manske CL, Wang Y, Wilson Rf, Rector T, White CW. Coronary revascularization in insulin dependent diabetic patients with chronic renal failure. Lancet. 1992; 340: 998-1002.
3. Braun WE, Phillips DF, Vidt DG. Coronary arteriography and coronary artey disease in 99 diabetic and nondiabetic patients on chronic hemodialysis or renal transplantation programs. Transplant Proc. 1981; 13: 128-35.
4. Langford EJ, Belder AJ, Cairns H, Hendrry BM, Wainwreight RJ. Non-invasive cardiac investigations in patients awaiting renal transplantation. J R Soc Med. 1997; 90: 136-7.
5. Abe S, Yashizawa M, Nakanishi N, Yazawa T, Yakota K, Honda M. Eletrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J. 1996; 131: 1137-44.
6. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martín CJ, Murria DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995; 47: 186-92.
7. Marwick TH, Steinmuller DR, Underwood DA, Hobbs RF, Swift C, Braun WE. Ineffectiveness of dipyridamole SPECT thalium imaging as an increening techinique for coronary artery diase in patient in patients with end-stage renal failure. Transplantion. 1990; 49: 100-3.
8. Boudreau RJ, Castaneda-Zuniga WR. Perfusion thalium imaging of type one diabeth patient with end-stage renal disease: comparation of oral and intravenous dipyradamole administration. Radiology. 1990; 175: 103-5.
9. Geleijnse ML, Fioretti PM, Roelandt JRTC. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol. 1997; 30: 595-606.
10. McNeill AJ, Fioretti PM, El-Said EM, Salustri A, Forster T, Roelandt JRTC. Enhanced sensivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol. 1992; 70: 41-6.
11. Shiller N, Shah P, Grawford M, Demaria A, Devereux R, Feigembaum H, et al. Recomendations for quantification of the left ventricle by two dimensional echocardiography. American Society of Echocardiography Committee on Standarts, subcommittee on quantitation of Two-Dimensional Echocardiograms. J Am Echo. 1989; 2: 358-67.
12. Devereux RB, Alonso DR, Lucas EM. Echocardiographic assesment of left ventricular hipertrophy: comparison to necropsy finding. Am J Cardiol. 1986; 57: 450-5.
13. Pellikka PA, Roger VL, Oh JK, Miller FA, Seward JB, Tajik J. Stress echocardiography. Part II. Dobutamine stress echocardiography: Techniques, implantation, clinical application, and correlation. Mayo Clin Proc. 1995; 70: 16-27.
14. Poldermans D, Fioretti PM, Boerma E. Safety of dobutamine atropine stress echocardiography in patients with suspected or proven coronary artery disease: experience in 650 consecutive examinations. Am J Cardiol. 1994; 73: 456-9.
15. Picano E, Mathias W, Pingitore R, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicenter study Lancet. 1994; 344: 1190-2.
16. Reis G, Marcovitz PA, Meichtman AB, Merion RM, Fay WP, Werns SW, et al. Usefulness of dobutamine stress echocardiography in detection of coronary artery disease in end-stage renal disease. Am J Cardiol. 1995; 75: 707-10.
17. Mathias W, Arruda A, Santos FC, Mattos E, Osório A, Campos O, et al. Safety of dobutamine-atropine stress echocardiography: a prospective experience of 4033 consecutive studies. J Am Soc Echocardiogr. 1999; 12: 785-91.
18. Secknus MA, Marwick TH. Evolution of dobutamine echocardiography protocols and indications: Safety and side effects in 3,011 studies over 5 years. J Am Coll Cardiol. 1997; 29: 1234-40.
19. Bates JR, Swada GS, Segar SD, Feigenbaum H, Ryan T. Evaluation using dobutamina stress echocardiography in patients with insulin dependent diabetes melitus before kidney and/or pancreas transplantation. Am J Cardiol. 1996; 77: 175-9.
20. Marcovitz PA, Bach DS, Mathias W, Shayna V, Armstrong WF. Paradoxic hypotension during dobutamine stress achocardiography: clinical and diagnostic implication. J Am Coll Cardiol. 1993; 21: 1080-6.
21. Tanimoto M, Pai RG, Jintapakorn W, Shah PM. Mechanism of hypotension during dobutamine stress echocardiography in patients with coronary artery disease. Am J Cardiol. 1995; 76: 26-30.
22. Herzog CA, Marwick TH, Pheley AM, White CW, Rao VK, Dick CD. Dobutamine stress echocardiography for the detection of signification coronary artery disease in renal transplant candidates. Am J Kidney Dis. 1999; 33: 1080-90.
23. Mertes H, Sawada SG, Ryan T. Symptoms, adverse effects and complications assaciated with dobutamine stress echocardiography: experience in 1118 patients. Circulation. 1993; 88: 15-9.
24. Cohen JL, Greene TO, Ottenweller J, Binenbaum SZ, Wilchfort SD, Kim CS. Dobutamine digital echocardiography for detecting coronary artery disease. Am J Cardiol. 1991; 67: 1311-8.
25. Rallids L, Cokkinos P, Tousoulis D, Nihoyannopoulos P. Comparison of dobutamine and treadmill exercise echocardiography in inducing ischemia in patients with coronary artery diseases. J Am Coll Cardiol. 1997; 30: 1660-8.
26. Salustri A, Fioretti PM, Mcneill AJ, Pozzoli MMA, Roelandt JRTC. Pharmacological stress echocardiography in the diagnosis of coronary artery disease and myocardial ischaemia: a comparison between dobutamine and dipyridamole. Eur Heart J. 1992; 13: 1356-62.
27. Previtale M, Lanzarini L, Fetiveau R, Poli , Ferrario M Falcone C, et al. Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease. Am J Cardiol. 1993; 72: 865-70.
28. Marwick TH, D'hondt AM, Baudhuin T, Willemart B, Wijns W, Detry JM, et al. Optimal use of dubotamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol. 1993; 22: 159-67.
29. Brennan DC, Vedala SB, Davila-Roman VG. Pretransplant dobutamine stress echocardiography is useful and cost-effective in renal transplant candidates. Transplant Proc. 1997; 29: 233-4.
30. De Lima JJG, Sabbaga E, Vieira MLC, de Paula FJ, Ianhez LE, Kriger EM, et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension. 2003; 42: 263-8.
31. Sawada SG, Segar DS, Ryan T, Brown SE, Dohan AL, Williams R, et al. Echocardiography detection of coronary artery disease during dobutamine infusion. Circulation. 1991; 83: 1605-14.
32. Mazeika PK, Nadazddin A, Oakley CM. Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol. 1992; 19: 1203-11.
33. Segar DS, Brown SE, Sawada SG. Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiography. J Am Coll Cardiol. 1992; 19: 1197-202.
34. Marcus ML, Koyanagi S, Harrison DG, Doty DB, Hiratzka LF, Eastham CL. Abnormalities in the coronary circulation that occur as a consequence of cardiac hypertrophy. Am J Med. 1983; 75: 62-6.